Research Highlights Benefits of GP-Prescribed Glucose Monitors
07 Jul 2026
Researchers say expanding access to CGM in primary care could help improve diabetes management, particularly for patients at higher risk of complications.
Published in JAMA Network Open, the study followed more than 8,500 people with diabetes in the United States. Of these, around 2,400 patients were prescribed a CGM by their GP for the first time.
After one year, patients using CGM showed greater improvements in HbA1c levels, a key measure of blood sugar control. They were also less likely to have repeat hospital admissions or emergency department visits compared to those not using the technology.
The researchers said the findings suggest that wider use of CGM in primary care could improve health outcomes and reduce pressure on hospitals, especially in underserved communities.
RACGP Specific Interests Diabetes Chair Dr Gary Deed said the study highlights the potential benefits of CGM but noted that cost remains a major barrier for many Australians. He said the technology can cost around $100 every two weeks, making ongoing use difficult for some patients.
Dr Deed said people living with social and economic disadvantage are often at greater risk of diabetes complications and could benefit most from improved access to CGM technology.
He encouraged GPs to discuss CGM with patients, particularly those who require insulin, and to ensure patients are aware of available monitoring options.
Dr Deed also stressed that effective diabetes care involves more than managing blood sugar levels, with heart health, kidney function, eye care, foot health, lifestyle factors and mental wellbeing all playing an important role.
Research Highlights Benefits of GP-Prescribed Glucose Monitors
Source: JAMA Network Open / newsGP, July 2026.